| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 121, 1784-1788, Copyright © 1987 by Endocrine Society
ARTICLES |
CF Van Schravendijk, A Foriers, JL Van den Brande and DG Pipeleers
Department of Metabolism and Endocrinology, Vrije Universiteit Brussel, Belgium.
Purified rat pancreatic islet cells express somatomedin receptors which are identified by their affinity for insulin-like growth factor (IGF)- I, IGF-II, and insulin. Binding of [125I]IGF-I to islet A cells was half-maximally inhibited by 7.10(-10) M IGF-I, while IGF-II, insulin, and proinsulin were respectively 10-, 500-, and 10,000-fold less potent displacers of IGF-I binding. Unrelated hormones such as glucagon or GH did not compete with [125I]IGF-I binding to A cells. The concentration of IGF-I receptors on A cells was estimated at 5000 IGF-I binding sites per cell with affinity constant (Ka) of 2 X 10(9) M-1. Islet B cells were found to exhibit a reversible time- and temperature-dependent binding with [125I]IGF-I. Specificity and affinity of IGF-I binding sites were identical for islet A and B cells. Linear Scatchard plots of competitive binding data on B cells suggest 1 single class of IGF-I receptors in a concentration of 12,000 sites per cell. The presence of high affinity receptors for IGF-I on adult islet A and B cells provides a molecular basis for this growth factor to influence growth, survival, and/or function of these endocrine cell types. Their low affinity for insulin should be considered as a potential mechanism for this hormone to influence, at high concentration, the function of islet A and B cells.
This article has been cited by other articles:
![]() |
S. Uhles, T. Moede, B. Leibiger, P.-O. Berggren, and I. B. Leibiger Selective gene activation by spatial segregation of insulin receptor B signaling FASEB J, May 1, 2007; 21(7): 1609 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fernandez, M. A. Martin, S. Fajardo, D. Bailbe, M. N. Gangnerau, B. Portha, F. Escriva, P. Serradas, and C. Alvarez Undernutrition does not alter the activation of beta-cell neogenesis and replication in adult rats after partial pancreatectomy Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E913 - E921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Flier, R. N. Kulkarni, and C. R. Kahn Evidence for a circulating islet cell growth factor in insulin-resistant states PNAS, June 7, 2001; (2001) 131192998. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers Glucose Sensing in Pancreatic {beta}-Cells: A Model for the Study of Other Glucose-Regulated Cells in Gut, Pancreas, and Hypothalamus Diabetes, January 1, 2001; 50(1): 1 - 11. [Abstract] [Full Text] |
||||
![]() |
D. J. Hill, B. Strutt, E. Arany, S. Zaina, S. Coukell, and C. F. Graham Increased and Persistent Circulating Insulin-Like Growth Factor II in Neonatal Transgenic Mice Suppresses Developmental Apoptosis in the Pancreatic Islets Endocrinology, March 1, 2000; 141(3): 1151 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Petrik, J. M. Pell, E. Arany, T. J. McDonald, W. L. Dean, W. Reik, and D. J. Hill Overexpression of Insulin-Like Growth Factor-II in Transgenic Mice Is Associated with Pancreatic Islet Cell Hyperplasia Endocrinology, May 1, 1999; 140(5): 2353 - 2363. [Abstract] [Full Text] |
||||
![]() |
J. Petrik, E. Arany, T. J. McDonald, and D. J. Hill Apoptosis in the Pancreatic Islet Cells of the Neonatal Rat Is Associated with a Reduced Expression of Insulin-Like Growth Factor II that May Act as a Survival Factor Endocrinology, June 1, 1998; 139(6): 2994 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Z. Zhao, H. Zhao, J. Teague, W. Fujimoto, and J. A. Beavo Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B PNAS, April 1, 1997; 94(7): 3223 - 3228. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Flier, R. N. Kulkarni, and C. R. Kahn Evidence for a circulating islet cell growth factor in insulin-resistant states PNAS, June 19, 2001; 98(13): 7475 - 7480. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |